• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从低剂量率前列腺近距离放射治疗计划向高剂量率计划的转变:比较初始剂量测定并通过有针对性的干预提高工作流程效率。

Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions.

作者信息

Solanki Abhishek A, Mysz Michael L, Patel Rakesh, Surucu Murat, Kang Hyejoo, Plypoo Ahpa, Bajaj Amishi, Korpics Mark, Martin Brendan, Hentz Courtney, Gupta Gopal, Farooq Ahmer, Baldea Kristin G, Pawlowski Julius, Roeske John, Flanigan Robert, Small William, Harkenrider Matthew M

机构信息

Department of Radiation Oncology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois.

Department of Radiation Oncology, University of Chicago, Chicago, Illinois.

出版信息

Adv Radiat Oncol. 2018 Oct 23;4(1):103-111. doi: 10.1016/j.adro.2018.10.004. eCollection 2019 Jan-Mar.

DOI:10.1016/j.adro.2018.10.004
PMID:30706017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349651/
Abstract

PURPOSE

We transitioned from a low-dose-rate (LDR) to a high-dose-rate (HDR) prostate brachytherapy program. The objective of this study was to describe our experience developing a prostate HDR program, compare the LDR and HDR dosimetry, and identify the impact of several targeted interventions in the HDR workflow to improve efficiency.

METHODS AND MATERIALS

We performed a retrospective cohort study of patients treated with LDR or HDR prostate brachytherapy. We used iodine-125 seeds (145 Gy as monotherapy, and 110 Gy as a boost) and preoperative planning for LDR. For HDR, we used iridium-192 (13.5 Gy × 2 as monotherapy and 15 Gy × 1 as a boost) and computed tomography-based planning. Over the first 18 months, we implemented several targeted interventions into our HDR workflow to improve efficiency. To evaluate the progress of the HDR program, we used linear mixed-effects models to compare LDR and HDR dosimetry and identify changes in the implant procedure and treatment planning durations over time.

RESULTS

The study cohort consisted of 122 patients (51 who received LDR and 71 HDR). The mean D90 was similar between patients who received LDR and HDR ( = .28). HDR mean V100 and V95 were higher ( < .0001), but mean V200 and V150 were lower ( < .0001). HDR rectum V100 and D1cc were lower ( < .0001). The HDR mean for the implant procedure duration was shorter (54 vs 60 minutes; = .02). The HDR mean for the treatment planning duration dramatically improved with the implementation of targeted workflow interventions (3.7 hours for the first quartile to 2.0 hours for the final quartile; < .0001).

CONCLUSIONS

We successfully developed a prostate HDR brachytherapy program at our institution with comparable dosimetry to our historic LDR patients. We identified several targeted interventions that improved the efficiency of treatment planning. Our experience and workflow interventions may help other institutions develop similar HDR programs.

摘要

目的

我们从低剂量率(LDR)前列腺近距离放射治疗方案过渡到高剂量率(HDR)方案。本研究的目的是描述我们开展前列腺HDR方案的经验,比较LDR和HDR剂量测定法,并确定HDR工作流程中几种有针对性干预措施对提高效率的影响。

方法和材料

我们对接受LDR或HDR前列腺近距离放射治疗的患者进行了一项回顾性队列研究。LDR使用碘-125种子(单药治疗为145 Gy,追加剂量为110 Gy)并进行术前规划。对于HDR,我们使用铱-192(单药治疗为13.5 Gy×2,追加剂量为15 Gy×1)并基于计算机断层扫描进行规划。在最初的18个月里,我们在HDR工作流程中实施了几种有针对性的干预措施以提高效率。为评估HDR方案的进展,我们使用线性混合效应模型比较LDR和HDR剂量测定法,并确定植入手术和治疗计划持续时间随时间的变化。

结果

研究队列包括122例患者(51例接受LDR,71例接受HDR)。接受LDR和HDR的患者之间平均D90相似( = 0.28)。HDR的平均V100和V95更高( < 0.0001),但平均V200和V150更低( < 0.0001)。HDR直肠V100和D1cc更低( < 0.0001)。植入手术持续时间的HDR平均值更短(54分钟对60分钟; = 0.02)。随着有针对性的工作流程干预措施的实施,治疗计划持续时间的HDR平均值显著改善(第一四分位数为3.7小时,最后四分位数为2.0小时; < 0.0001)。

结论

我们在本机构成功开展了前列腺HDR近距离放射治疗方案,其剂量测定法与我们既往的LDR患者相当。我们确定了几种提高治疗计划效率的有针对性干预措施。我们的经验和工作流程干预措施可能有助于其他机构开展类似的HDR方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/6349651/2841b5b80a07/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/6349651/5675534ab1e7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/6349651/1b1319f6b741/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/6349651/2841b5b80a07/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/6349651/5675534ab1e7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/6349651/1b1319f6b741/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/6349651/2841b5b80a07/gr3.jpg

相似文献

1
Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions.从低剂量率前列腺近距离放射治疗计划向高剂量率计划的转变:比较初始剂量测定并通过有针对性的干预提高工作流程效率。
Adv Radiat Oncol. 2018 Oct 23;4(1):103-111. doi: 10.1016/j.adro.2018.10.004. eCollection 2019 Jan-Mar.
2
Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.低剂量率与高剂量率间质前列腺近距离放射治疗作为单一疗法的患者治疗计划的剂量学比较:一项随机临床试验的初步结果
Brachytherapy. 2017 May-Jun;16(3):608-615. doi: 10.1016/j.brachy.2017.02.003. Epub 2017 Mar 18.
3
A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.一种使用针数和雄激素剥夺来预测高剂量率或低剂量率前列腺近距离放射治疗慢性尿路毒性的新模型。
J Urol. 2005 Sep;174(3):882-7. doi: 10.1097/01.ju.0000169136.55891.21.
4
Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial.高剂量率(HDR)与低剂量率(LDR)单一疗法对前列腺内主要病灶的剂量:一项II期随机试验。
Brachytherapy. 2019 May-Jun;18(3):299-305. doi: 10.1016/j.brachy.2019.01.006. Epub 2019 Feb 20.
5
Conventional vs machine learning-based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial.前列腺近距离放射治疗中基于传统方法与机器学习的治疗计划对比:一项I期随机对照试验的结果
Brachytherapy. 2020 Jul-Aug;19(4):470-476. doi: 10.1016/j.brachy.2020.03.004. Epub 2020 Apr 19.
6
High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.与低剂量率钯籽源相比,高剂量率近距离放射疗法作为前列腺癌单一疗法可降低毒性。
J Urol. 2004 Mar;171(3):1098-104. doi: 10.1097/01.ju.0000113299.34404.22.
7
Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer.容积调强弧形放疗、高剂量率近距离放疗和低剂量率永久性粒子植入治疗局限性前列腺癌的剂量学和放射生物学比较。
Med Dosim. 2016 Autumn;41(3):236-41. doi: 10.1016/j.meddos.2016.06.002. Epub 2016 Jul 9.
8
Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.实时术中与术后剂量测定之间的相关性及其对术中规划的影响。
Brachytherapy. 2019 May-Jun;18(3):338-347. doi: 10.1016/j.brachy.2018.12.004. Epub 2019 Jan 14.
9
Live implant dosimetry may be an effective replacement for postimplant computed tomography in localized prostate cancer patients receiving low dose rate brachytherapy.对于接受低剂量率近距离放射治疗的局限性前列腺癌患者,活体植入剂量测定法可能是替代植入后 CT 的有效方法。
Brachytherapy. 2021 Jul-Aug;20(4):873-882. doi: 10.1016/j.brachy.2021.02.008. Epub 2021 Apr 8.
10
Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.宫颈癌患者近距离放射治疗实践模式(1996 - 1999年):一项医疗服务模式研究
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1083-92. doi: 10.1016/j.ijrobp.2005.04.035. Epub 2005 Aug 15.

引用本文的文献

1
Assessment of treatment plans from high-dose-rate-brachytherapy of prostate cancer in Nigeria: findings from pioneer centre.尼日利亚前列腺癌高剂量率近距离放射治疗治疗计划评估:来自先驱中心的研究结果。
Ecancermedicalscience. 2025 May 15;19:1906. doi: 10.3332/ecancer.2025.1906. eCollection 2025.
2
Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer.LDR 与 HDR 单药近距离治疗前列腺癌的围手术期和亚急性术后并发症比较。
Brachytherapy. 2024 Sep-Oct;23(5):559-568. doi: 10.1016/j.brachy.2024.06.001. Epub 2024 Jul 26.
3
Dose Distribution of High Dose-Rate and Low Dose-Rate Prostate Brachytherapy at Different Intervals-Impact of a Hydrogel Spacer and Prostate Volume.

本文引用的文献

1
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.一项随机试验的长期结果:比较铱植入联合外照射放疗与单纯外照射放疗用于前列腺淋巴结阴性局部晚期癌的疗效
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):90-93. doi: 10.1016/j.ijrobp.2017.05.013. Epub 2017 May 17.
2
Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer.单剂量高剂量率近距离治疗与两三个剂量分次治疗局部晚期前列腺癌的比较。
Radiother Oncol. 2017 Jul;124(1):56-60. doi: 10.1016/j.radonc.2017.06.014. Epub 2017 Jun 27.
3
不同间隔下高剂量率和低剂量率前列腺近距离放射治疗的剂量分布——水凝胶间隔物和前列腺体积的影响
Cancers (Basel). 2023 Feb 22;15(5):1396. doi: 10.3390/cancers15051396.
4
Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate Cancer.前列腺癌退伍军人接受根治性高剂量率近距离放射治疗后的健康相关生活质量和毒性反应
Fed Pract. 2021 Aug;38(Suppl 3):S52-S56. doi: 10.12788/fp.0147.
5
Computed tomography versus magnetic resonance imaging in high-dose-rate prostate brachytherapy planning: The impact on patient-reported health-related quality of life.计算机断层扫描与磁共振成像在高剂量率前列腺近距离治疗计划中的比较:对患者报告的健康相关生活质量的影响。
Brachytherapy. 2021 Jan-Feb;20(1):66-74. doi: 10.1016/j.brachy.2020.09.002. Epub 2020 Nov 5.
6
Deep learning-based digitization of prostate brachytherapy needles in ultrasound images.基于深度学习的超声图像中前列腺近距离治疗针数字化
Med Phys. 2020 Dec;47(12):6414-6420. doi: 10.1002/mp.14508. Epub 2020 Oct 27.
7
Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval.患者和医生报告了两分割根治性高剂量率前列腺近距离放射治疗的毒性反应:植入间隔的影响
J Contemp Brachytherapy. 2020 Jun;12(3):216-224. doi: 10.5114/jcb.2020.96861. Epub 2020 Jun 30.
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.
雄激素抑制联合选择性淋巴结及剂量递增放射治疗(ASCENDE-RT试验):一项针对高风险和中风险前列腺癌的随机试验的生存终点分析,该试验比较了低剂量率近距离放疗增敏与剂量递增外照射增敏。
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):275-285. doi: 10.1016/j.ijrobp.2016.11.026. Epub 2016 Nov 24.
4
Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.19Gy单次分割高剂量率近距离放射治疗低危和中危前列腺癌男性患者的初步良好结果
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):98-106. doi: 10.1016/j.ijrobp.2016.08.011. Epub 2016 Nov 9.
5
Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency Training.学术性与非学术性医疗机构的前列腺近距离放射治疗病例数量:对未来住院医师培训的启示
Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):624-8. doi: 10.1016/j.ijrobp.2016.07.013. Epub 2016 Jul 25.
6
Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.基于术中超声的计划能够有效替代基于术后CT的计划,用于前列腺癌的高剂量率近距离放射治疗。
Brachytherapy. 2016 Jul-Aug;15(4):399-405. doi: 10.1016/j.brachy.2016.04.003. Epub 2016 May 12.
7
Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer.高剂量率近距离放射治疗单药治疗低危前列腺癌的三种治疗方案的相关结果。
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):657-66. doi: 10.1016/j.ijrobp.2015.10.011. Epub 2015 Nov 10.
8
High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results.高剂量率单药治疗局限性前列腺癌:10年结果
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):667-74. doi: 10.1016/j.ijrobp.2015.07.2290. Epub 2015 Aug 5.
9
Declining use of brachytherapy for the treatment of prostate cancer.近距离放射疗法在前列腺癌治疗中的使用减少。
Brachytherapy. 2014 Mar-Apr;13(2):157-62. doi: 10.1016/j.brachy.2013.08.005. Epub 2013 Sep 17.
10
High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.高剂量率前列腺近距离治疗始终能获得高质量的剂量学结果。
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):543-8. doi: 10.1016/j.ijrobp.2012.03.035. Epub 2012 May 30.